Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
|
|
49.
|
|
|
50.
|
|
|
51.
|
|
|
52.
|
|
|
53.
|
|
|
54.
|
|
|
55.
|
Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface. [electronic resource] by
- Guthridge, J M
- Young, K
- Gipson, M G
- Sarrias, M R
- Szakonyi, G
- Chen, X S
- Malaspina, A
- Donoghue, E
- James, J A
- Lambris, J D
- Moir, S A
- Perkins, S J
- Holers, V M
Producer: 20011207
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 167
Availability: No items available.
|
|
56.
|
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. [electronic resource] by
- Moir, S
- Malaspina, A
- Ogwaro, K M
- Donoghue, E T
- Hallahan, C W
- Ehler, L A
- Liu, S
- Adelsberger, J
- Lapointe, R
- Hwu, P
- Baseler, M
- Orenstein, J M
- Chun, T W
- Mican, J A
- Fauci, A S
Producer: 20011004
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 98
Availability: No items available.
|
|
57.
|
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort. [electronic resource] by
- Plevris, N
- Chuah, C S
- Allen, R M
- Arnott, I D
- Brennan, P N
- Chaudhary, S
- Churchhouse, A M D
- Din, S
- Donoghue, E
- Gaya, D R
- Groome, M
- Jafferbhoy, H M
- Jenkinson, P W
- Lam, W L
- Lyons, M
- Macdonald, J C
- MacMaster, M
- Mowat, C
- Naismith, G D
- Potts, L F
- Saffouri, E
- Seenan, J P
- Sengupta, A
- Shasi, P
- Sutherland, D I
- Todd, J A
- Veryan, J
- Watson, A J M
- Watts, D A
- Jones, G R
- Lees, C W
Producer: 20200212
In:
Journal of Crohn's & colitis vol. 13
Availability: No items available.
|